Abstract
Age-related macular degeneration (AMD) has a number of characteristic features including late onset and accumulation of deposits (drusen) below the retinal pigment epithelium on Bruch’s membrane in the macula. A progressive increase in these deposits (in some individuals) leads to macular blindness, following either the local loss of the retinal pigment epithelium (geographic atrophy) or the hemorrhage of new blood vessels that originate in the choroid and invade the compartment between the photoreceptors and retinal pigment epithelium (choroidal neovascularization). Over the last few years a number of mouse models for AMD have been described that replicate some of the changes manifest in the human disease. This chapter begins with a description of the hallmarks of AMD, discusses some of the ideas about the underlying mechanisms and then summarizes the features of AMD found in experimental animals that are purported to model this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Javitt J, Zhou Z, Maguire M, Fine S, Willke R (2003) Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 110:1534-1539
Augood C, Vingerling J, de Jong P et al (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124:529-535
Curcio C, Millican C, Bailey T, Kruth H (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42:265-274
Hussain A, Rowe L, Marshall J (2002) Age-related alterations in the diffusional transport of amino acids across the human Bruch’s-choroid complex. J Opt Soc Am A Opt Image Sci Vis 19:166-172
Moore D, Hussain A, Marshall J (1995) Age-related variation in the hydraulic conductivity of Bruch’s membrane. Invest Ophthalmol Vis Sci 36:1290-1297
Bressler S, Maguire M, Bressler N, Fine S (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 108:1442-1447
Sarks S, van Driel D, Maxwell L, Killingsworth M (1980) Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc UK 100:414-422
Vinding T (1990) Occurrence of drusen, pigmentary changes, and exudative changes in the macula with reference to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol 68:410-414
Holz F, Bellman C, Staudt S, Schutt F, Volcker H (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42:1051-1056
Martinez-Mir A, Paloma E, Allikmets R et al (1998) Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nature Genet 18:11-12
Zhang K, Kniazeva M, Han M et al (2001) A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27:89-93
Stone E, Lotery A, Munier F et al (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22:199-202
Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) in patients with Sorsby’s fundus dystrophy. Nat Genet 8:352-356
Petrukhin K, Koisti MJ, Bakall B et al (1998) Identification of the gene responsible for Best macular dystrophy. Nature Genet 19:241-247
Sun H, Tsunenari T, Yau K-W, Nathans J (2002) The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA 99(6):4008-4013
Stone E, Sheffield V, Hageman G (2001) Molecular genetics of age-related macular degeneration. Hum Mol Genet 10:2285-2292
Hageman G, Mullins R (1999) Molecular composition of drusen as related to substructural phenotype. Mol Vis 5:28-37
Johnson L, Leitner W, Staples M, Anderson D (2001) Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73:887-896
Anderson D, Mullins R, Hageman G, Johnson L (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411-431
Hageman G, Luthert PJ, Chong N, Johnson L, Anderson D, Mullins R (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705-732
Crabb J, Miyagi M, Gu X et al (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99:14682-14687
Johnson L, Ozaki S, Staples M, Erickson P, Anderson D (2000) A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70:441-449
Doyne RW (1989) Peculiar condition of choroiditis occurring in several members of the same family. Trans Ophthalmol Soc UK 19:71-77
Gass JDM (1987) Stereoscopic atlas of macular diseases. C.V. Mosby, St. Louis
Meyers SM, Zachary AA (1988) Monozygotic twins with age-related macular degeneration. Arch Ophthalmol 106:651-653
Seddon JM, Ajani U, Mitchell B (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123:199-206
Klein R, Zeiss C, Chew E et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389
Edwards A, Ritter R, Abel K, Manning A, Panhuysen C, Farrer L (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421-424
Hageman G, Anderson D, Johnson L et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227-7232
Haines J, Hauser M, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421
Gold B, Merriam J, Zernant J et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nature Genet 38:458-462
Ennis S, Jomary C, Mullins R et al (2008) Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 372:1788-1789
Eldred G (1998) Lipofuscin and other lysosomal storage deposits in the retinal pigment epithelium. In: Marmor M, Wolfensberger T (eds) The retinal pigment epithelium. Oxford University Press, Oxford, pp 651-668
Sparrow J, Boulton M (2005) RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 80:595-606
Sparrow J (2007) RPE lipofuscin: formation, properties, and felevance to retinal degeneration. In: Tombran-Tink J, Barnstable CJ (eds) Retinal degenerations: biology, diagnostics and therapeutics. Humana Press, Totowa, NJ, pp 213-236
Boulton M, Dontsov A, Jarvis-Evans J, Ostrovsky M, Svistunenko D (1993) Lipofuscin is a photoinducible free radical generator. J Photochem Photobiol B 19:201-204
Wassell J, Davies S, Bardsley W, Boulton M (1999) The photoreactivity of the retinal age pigment lipofuscin. J Biol Chem 274:23828-23832
Sparrow J, Nakanishi K, Parish C (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981-1989
Sparrow J, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K (2002) Involvement of oxidative mechanisms in blue light induced damage to A2E-laden RPE. Invest Opthalmol Vis Sci 43:1222-1227
Zhou J, Jang Y, Kim S, Sparrow J (2006) Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA 103:16182-16187
Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer’s Abeta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 99(18):11830-11835
Gu X, Meer S, Miyagi M et al (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278:42027-42035
Anderson R, Lissandrello P, Maude M, Matthes M (1976) Lipids of bovine retinal pigment epithelium. Exp Eye Res 23:149-157
Anderson RE (1970) Lipids of the ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. Exp Eye Res 10:339-344
Fliesler SJ, Anderson RE (1983) Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 22:79-131
Hollyfield J, Crabb J, Salomon R (2003) Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol 533:83-89
Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276:1141-1146
Klein R, Klein B, Cruickshanks K (1999) The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18:371-389
Snow K, Seddon J (1999) Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 6:125-143
Christen W, Glynn R, Manson J, Ajani U, Buring J (1996) A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276:1147-1151
Solberg Y, Rosner M, Belkin M (1998) The association between cigarette smoking and ocular diseases. Surv Ophthalmol 42:535-547
Hollyfield J, Bonilha V, Lu L et al (2008) Oxidative damage induced inflammation initiates age-related macular degeneration. Nat Med 14:194-198
Cousins S, Espinosa-Heidmann D, Alexandridou A, Sall J, Dubovy S, Csaky K (2002) The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp Eye Res 75:543-553
Cousins S, Marin-Castaño M, Espinosa-Heidmann D, Alexandridou A, Striker L, Elliot S (2003) Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci 44:1221-1229
Majji A, Cao J, Chang K et al (2000) Age-related retinal pigment epithelium and Bruch’s membrane degeneration in senescence-accelerated mouse. Invest Ophthalmol Vis Sci 41:3936-3942
Smith W, Mitchell P, Leeder S (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114:1518-1523
Espinosa-Heidmann D, Suner I, Catanuto P, Hernandez E, Marin-Castano M, Cousins S (2006) Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 47(2):729-737
Baird P, Guida E, Chu D, Vu H, Guymer R (2004) The 2 and 4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45:1311-1315
Malek G, Johnson L, Mace B et al (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA 102:11900-11905
Rakoczy P, Zhang D, Robertson T et al (2002) Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol 181:1515-1524
Ambati J, Anand A, Fernandez S et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nature Med 9:1390-1397
Tuo J, Smith B, Bojanowski C et al (2004) The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18:1297-1299
Tuo J, Bojanowski C, Zhou M et al (2007) Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 48:3827-3836
Chang B, Mandal M, Chavali V et al (2008) Age-related retinal degeneration (arrd2) in a novel mouse model due to a nonsense mutation in the Mdm1 gene. Hum Mol Genet 17:3929-3941
Imamura Y, Noda S, Hashizume K et al (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci USA 103:11282-11287
Hadziahmetovic M, Dentchev T, Song Y et al (2008) Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49:2728-2736
Tanaka N, Ikawa M, Mata N, Verma I (2006) Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Mol Ther 13:609-616
Clark S, Higman V, Mulloy B et al (2006) His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem 281:24713-24720
Prosser B, Johnson S, Roversi P et al (2007) Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204:2277-2283
Haapasalo K, Jarva H, Siljander T, Tewodros W, Vuopio-Varkila J, Jokiranta T (2008) Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Mol Microbiol 70:583-594
Coffey P, Gias C, McDermott C et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci USA 104:16651-16656
Gu X, Sun M, Hazen S, Crabb J, Salomon R (2003) Oxidatively truncated docosahexaenoate phosphoplipids: total synthesis, generation and peptide adduction chemistry. J Org Chem 68:3749-3761
Umeda S, Suzuki M, Okamoto H et al (2005) Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J 19:1683-1685
Umeda S, Ayyagari R, Allikmets R, Suzuki MT, Karoukis AJ, Ambasudhan R, Zernant J, Okamoto H, Ono F, Terao K, Mizota A, Yoshikawa Y, Tanaka Y, Iwata T (2005) Early-onset macular degeneration with drusen in a cynomolgus monkey (Macaca fascicularis) pedigree: exclusion of 13 candidate genes and loci. Invest Ophthalmol Vis Sci 46:683-691
Iwata T (2007) Complement activation of drusen in primate model (Macaca fascicularis) for age-related macular degeneration. Adv Exp Med Biol 598:251-259
Kaidzu S, Tanito M, Ohira A et al (2008) Immunohistochemical analysis of aldehyde-modified proteins in drusen in cynomolgus monkeys (Macaca fascicularis). Exp Eye Res 86:856-859
Singh K, Krawczak M, Dawson W, Schmidtke J (2009) Association of HTRA1 and ARMS2 gene variation with drusen formation in rhesus macaques. Exp Eye Res 88(3):479-482
Francis P, Appukuttan B, Simmons E et al (2008) Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. Hum Mol Genet 17:2673-2680
Green WR, Enger C (1993) Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman lecture. Ophthalmology 100:1519-1535
El-Mofty A, Gouras P, Eisner G, Balazs E (1978) Macular degeneration in rhesus monkey (Macaca mulatta). Exp Eye Res 27:499-502
Hope G, Dawson W, Engel H, Ulshafer R, Kessler M, Sherwood M (1992) A primate model for age related macular drusen. Br J Ophthalmol 76:11-16
Gouras P, Ivert L, Mattison J, Ingram D, Neuringer M (2008) Drusenoid maculopathy in rhesus monkeys: autofluorescence, lipofuscin and drusen pathogenesis. Graefes Arch Clin Exp Ophthalmol 246:1403-1411
Tatusova TA, Madden TL (1999) Blast 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174:247-250
Acknowledgment
The authors research is supported by grants from the National Institutes of Health, National Eye Institute, Bethesda, MD; the State of Ohio, BRTT Program, Columbus, OH; the Foundation Fighting Blindness, Owings Mills, MD; and Research to Prevent Blindness, New York, NY. We thank Mary E. Rayborn for help with editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hollyfield, J.G., Kuttner-Kondo, L. (2010). Animal Models for Age-Related Macular Degeneration. In: Pang, IH., Clark, A. (eds) Animal Models for Retinal Diseases. Neuromethods, vol 46. Humana Press. https://doi.org/10.1007/978-1-60761-541-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-541-5_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-540-8
Online ISBN: 978-1-60761-541-5
eBook Packages: Springer Protocols